Trevi Therapeutics
Rebecca (Peggi) Drain serves as the Vice President of Global Regulatory Affairs at Trevi Therapeutics, Inc. since August 2022, bringing over 25 years of extensive drug development experience in the biopharma industry. Prior to this role, Rebecca held various positions at Intensity Therapeutics, Inc. as Senior Director of Global Regulatory Affairs and at Bristol-Myers Squibb Co., where roles included Vice President of Regulatory Affairs and Quality Assurance as well as Executive Director of Regulatory Affairs and Quality Assurance, focusing on global regulatory dossier guidance and submission strategy. Rebecca’s academic background includes a Bachelor of Science in Pathobiology from the University of Connecticut.
This person is not in any teams
This person is not in any offices
Trevi Therapeutics
1 followers
Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.